Research location
Fayetteville
Arkansas, United States
Advertisement
Research activity in Fayetteville
Arkansas, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 244 trials and 249 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Fayetteville
244 linked trials · page 1 of 5Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersNCT07227298 · 2026-01-30 · 1 site observation
RECRUITING
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT07222566 · 2026-01-06 · 1 site observation
RECRUITING
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung CancerNCT07226999 · 2025-12-09 · 1 site observation
RECRUITING
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerNCT07181161 · 2025-10-01 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)NCT07144280 · 2025-09-29 · 1 site observation
RECRUITING
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.NCT07028853 · 2025-09-28 · 1 site observation
RECRUITING
Physical Activity and Community EmPOWERment ProjectNCT06740162 · 2025-01-10 · 1 site observation
RECRUITING
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the BodyNCT06470243 · 2024-11-27 · 1 site observation
RECRUITING
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.NCT06629779 · 2024-10-22 · 1 site observation
RECRUITING
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT06417814 · 2024-10-04 · 1 site observation
RECRUITING
ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416 · 2024-10-02 · 1 site observation
RECRUITING
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844 · 2024-07-19 · 1 site observation
RECRUITING
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.NCT05939414 · 2024-03-12 · 1 site observation
RECRUITING
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerNCT05929768 · 2023-09-15 · 1 site observation
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabNCT05812807 · 2023-06-14 · 1 site observation
RECRUITING
Time Restricted Feeding, Muscle, and MetabolismNCT04949451 · 2021-06-13 · 1 site observation
RECRUITING
Parkinson's Foundation PD GENEration Genetic RegistryNCT04994015 · 2020-12-20 · 1 site observation
RECRUITING
A Study of Sigvotatug Vedotin in Advanced Solid TumorsNCT04389632 · 2020-06-08 · 1 site observation
RECRUITING
To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 YearsNCT07387393 · 2026-05-01 · 1 site observation
ENROLLING_BY_INVITATION
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseNCT06760637 · 2025-01-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.NCT06704724 · 2024-12-10 · 1 site observation
TERMINATED
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerNCT06580938 · 2024-11-11 · 1 site observation
TERMINATED
Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot StudyNCT06471595 · 2024-09-01 · 1 site observation
COMPLETED
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.NCT06447662 · 2024-06-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical FrameworkNCT06461416 · 2024-06-10 · 1 site observation
COMPLETED
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In CombinationNCT06448364 · 2024-05-09 · 1 site observation
TERMINATED
Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · 2024-03-13 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.NCT06206837 · 2024-02-19 · 1 site observation
ACTIVE_NOT_RECRUITING
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)NCT06125522 · 2024-01-10 · 1 site observation
COMPLETED
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)NCT05952557 · 2023-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)NCT05607550 · 2023-06-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic ImagesNCT05857943 · 2023-03-29 · 1 site observation
COMPLETED
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung StudyNCT05633602 · 2023-03-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract SurgeryNCT05624398 · 2022-12-07 · 1 site observation
UNKNOWN
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsNCT05538130 · 2022-11-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung CancerNCT05403385 · 2022-08-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle GlaucomaNCT05411198 · 2022-07-22 · 1 site observation
COMPLETED
Roll-over Study to Allow Continued Access to RibociclibNCT05161195 · 2022-07-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701 · 2022-07-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseNCT05310071 · 2022-06-02 · 1 site observation
TERMINATED
Diabetes Self-Management Education with Sleep HygieneNCT04420845 · 2022-03-25 · 1 site observation
WITHDRAWN
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle GlaucomaNCT05280366 · 2022-02-09 · 1 site observation
UNKNOWN
Screening for High Frequency Malignant DiseaseNCT05117840 · 2022-01-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Home Food Delivery for Diabetes Management in Patients of Rural ClinicsNCT04876053 · 2021-10-22 · 2 site observations
COMPLETED
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringNCT04597359 · 2021-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast TissueNCT05268224 · 2021-10-01 · 1 site observation
UNKNOWN
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot StudyNCT05223218 · 2021-08-25 · 1 site observation
UNKNOWN
Delivering Health: Addressing Diabetes and Food InsecurityNCT04831216 · 2021-08-24 · 1 site observation
COMPLETED
Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.NCT05024695 · 2021-08-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.NCT04881045 · 2021-08-18 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.